Drugs / V0034CR01B
last change May 2012 re-read 2 minutes ago

V0034CR01B

Developed for
atopic eczema
Investigated by
Orfagen · Pierre Fabre Laboratories

Trials 2 · a red edge is where a trial was stopped

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01467362 Nov 2011 → May 2012 atopic eczema Pierre Fabre Laboratories Completed No outcome recorded
Phase 3 NCT01084148 Jan 2007 → Jan 2009 Orfagen Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as V0034CR01B ClinicalTrials.gov intervention name — accepted as the source's own label NCT01084148
1

NCT01467362